TDK-Lambda's EFE300M digital power supplies meet latest medical approvals


Full safety approval to 2nd and 3rd Editions is assured during transition period

Click image to enlarge

TDK Corporation announces that the TDK-Lambda EFE300M is now approved to IEC/EN 60601-1, ANSI/AAMI ES60601-1 and CAN/CSA-C22.2 No 60601-1-08 3rd Edition medical safety standards - this is in addition to the current approval to the 2nd Edition, ensuring full safety approval for medical equipment is maintained during the transition period from 2nd to 3rd Editions. Typical medical applications for the EFE300M range include clinical diagnostic systems, medical imaging equipment, dialysis systems and medical lasers. With a 6x3" footprint and a 1U profile, the EFE300M can be incorporated easily in designs where space is limited, so end equipment can be smaller, cooler and more feature rich. Other features such as redundant operation (complete with in-built Oring FET) and a high current standby output make the EFE300M equally suitable for high integrity applications including broadcast, instrumentation, routers, servers and security networks. Other suitable applications include ATE and automation. "We are approved by the Underwriters Laboratories® Inc. (UL) to 60601-1 3rd Edition, which helps us to ensure that our medical power supplies are tested and approved to the highest safety standards," says Bob Taylor, Safety Engineering Manager at TDK-Lambda UK. The power supply manufacturer has actively participated in the Underwriters Laboratories® Inc. (UL) ‘Clients Test Data Program' (CTDP) and the IECEE CB Scheme SMT (Supervised Manufacturer's Test) Program, which is now also under the supervision of UL, for over 16 years. Being on these programs allows TDK-Lambda to use its own testing facilities to generate UL and CB safety reports and test data, this capability helps to reduce time and the accompanying costs for the safety approvals of its own AC-DC power supplies and DC-DC converters.